Brief: Novo Nordisk Sees Wegovy To Be Available In UK Via Private Prescription Within Weeks
BRIEF-Novo Nordisk Sees Wegovy To Be Available In UK Via Private Prescription Within Weeks June 11 (Reuters) - Novo Nordisk A/S NOVOb.CO:
NOVO NORDISK: WEGOVY® PILL (SEMAGLUTIDE TABLETS) BECOMES FIRST DAILY GLP-1 WEIGHT-LOSS PILL APPROVED IN THE UK
NOVO NORDISK - EXPECTS WEGOVY PILL AVAILABLE VIA PRIVATE PRESCRIPTION IN UK WITHIN WEEKS
Source text: ID:nGNE1M00LH
Further company coverage: [NOVOb.CO]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novo Nordisk A/S
See all newsUK Stocks-Factors to watch on June 12 (updated)
UK Stocks-Factors to watch on June 12
Brief: Novo Nordisk reports patient data breach from some clinical trials in IT security incident
Novo Nordisk flags patient data breach from some clinical trials in cyberattack (updated)
Novo Nordisk says security incident has access to limited internal IT systems